Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea
May 03, 2022 18:50 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results
April 11, 2022 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
April 11, 2022 08:15 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 million...
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV
February 14, 2022 08:10 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation...
Trinity Biotech Announces The Successful Closing of its Debt Refinancing
January 27, 2022 17:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022
January 25, 2022 08:15 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
December 15, 2021 18:21 ET
|
Trinity Biotech plc
DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech Announces Results for Q2, 2021
September 09, 2021 08:45 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results
August 31, 2021 16:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Provides A Business Development Update For Q2 2021
July 16, 2021 08:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021. HIV Testing (TrinScreen™ HIV) Trinity Biotech has been the...